Prime Medicine Inc.

2.23
-0.29 (-11.51%)
At close: Mar 03, 2025, 3:59 PM
2.28
2.24%
After-hours: Mar 03, 2025, 04:22 PM EST

Prime Medicine Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Net Income -195.88M -198.13M -121.82M -165.37M -3.41M -2.53M
Depreciation & Amortization 6.13M 4.65M 2.22M 568K 43K n/a
Stock-Based Compensation 26.07M 13.91M 6.46M 1.75M 391K n/a
Other Working Capital 36.33M -6.49M -37.86M 29.99M -86K 492K
Other Non-Cash Items 9.74M 11.79M 17.68M 98.42M -4.6M 703K
Deferred Income Tax n/a -279K -964K -624K 1.87M n/a
Change in Working Capital 31.08M 2.65M -35.4M 31.18M 164K 492K
Operating Cash Flow -122.86M -165.41M -131.83M -34.08M -5.54M -1.33M
Capital Expenditures -7.29M -8.72M -16.09M -4.15M -639K n/a
Acquisitions n/a n/a n/a n/a n/a n/a
Purchase of Investments -91.37M -104.95M -123.34M -81.98M n/a n/a
Sales Maturities Of Investments 204.2M 132.56M 93M 13M n/a n/a
Other Investing Acitivies -37.08M -170K -665K -496K -423K n/a
Investing Cash Flow 68.46M 18.71M -47.1M -73.63M -1.06M n/a
Debt Repayment n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 25.74M 655K -3.82M 269.28M 34.93M 9.98M
Financial Cash Flow 195.88M 655K 181.49M 269.28M 34.93M 9.98M
Net Cash Flow 141.47M -146.05M 2.57M 161.57M 28.33M 8.65M
Free Cash Flow -130.16M -174.14M -147.92M -38.23M -6.18M -1.33M